Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "Us Injectables Llc"

Linde to Resolve Injection Molding Issues with Gas-Based Solutions
World Industrial Reporter

Linde to Resolve Injection Molding Issues with Gas-Based Solut...

Linde LLC has developed a new series of carbon dioxide (CO2) and liquid nitrogen supply and control systems to help plastic injection molders reduce cycle times, increase production and solve hot spot challenges. Linde will simultaneously promote ... World Industrial Reporter, 1 week ago

FDA Approves New Varicose Vein Treatment

The US Food and Drug Administration (FDA) has approved the VenaSeal closure system (Covidien LLC), the first device to permanently treat varicose veins by sealing them with an adhesive agent. Varicose veins often cause no symptoms, but some ...
 Dermatology Online Journal1 week ago FDA clears closure system to permanently treat varicose veins  Formulary Journal1 week ago FDA Recommends Varicose Vein Treatment for Legs  NewsHub South Africa1 week ago FDA approves closure system to permanently treat varicose veins  Medical News Today1 week ago
[x]  

Lone Star Value Seeks To Upgrade Ciber's Board Of Directors

NEW YORK , Feb. 27, 2015 /PRNewswire/ --Lone Star Value Management, LLC (together with its affiliates, "Lone Star Value", "we", or "us") is a significant, long-term shareholder of Ciber, Inc. ("Ciber" or the "Company") ( NYSE: CBR ) with ownership ...
 Securities Technology Monitor4 days ago CIBER : Lone Star Value Seeks To Upgrade Ciber's Board Of Directors  4 Traders4 days ago Press Release: Lone Star Value Seeks To Upgrade Ciber's Board Of Directors  iMarketReports4 days ago
[x]  

EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion

TARRYTOWN, N.Y., Feb. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular ...
 TickerTech.com5 days ago EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion  Healthcare Sales & Marketing Network4 days ago EYLEA (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion  Pharmacy Choice4 days ago EYLEA?? (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion  Review Seeker5 days ago
[x]  
Industrial Info Financials

Bayer Presents Latest Oncology Research at ASCO GU 2015

Bayer HealthCare Pharmaceuticals Inc. announced today that new data on Xofigo® (radium Ra 223 dichloride) injection will be presented at the 2015 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO GU) taking place ...
 Individual.com1 week ago
[x]  

Aegis Awarded U.S. Patent No. 8,927,497 for Non-Invasive Delivery of Anti-Seizure Drugs

SAN DIEGO, CA -- (Marketwired) -- 02/18/15 -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,927,497 providing broad coverage for non-invasive delivery of anti-seizure drugs via a simple metered nasal spray. The ...
 Town Hall1 week ago Aegis Therapeutics, LLC Awarded U.S. Patent No. 8,927,497 For Non-Invasive Delivery Of Anti-Seizure Drugs  BioSpace1 week ago
[x]  

Patent Issued for Fuel Injection Control Device for Engine

By a News Reporter-Staff News Editor at Journal of Engineering -- From Alexandria, Virginia , VerticalNews journalists report that a patent by the inventors Katsurahara, Hiroshi ( Okazaki , JP); Fukasawa , Osamu ( Nagoya , JP); Nakano , Tomoaki ...
 4 Traders5 days ago UNITED TECHNOLOGIES : Patent Issued for Gas Turbine Engine Staged Fuel Injection Using Adjacent Bluff Body and Swirler Fuel Injectors  4 Traders1 week ago BASSO INDUSTRY : Researchers Submit Patent Application, "Fastener Feeding Device for a Driving Tool", for Approval  4 Traders5 days ago Denso : Patent Issued for Fuel-Pressure-Sensor Diagnosis Device  4 Traders5 days ago

Teva launches injectable generic Lovenox and Zyvox [Globes, Tel Aviv, Israel]

Feb. 18Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has launched the generic equivalent of Lovenox (enoxaparin sodium injection) in seven injectable dosage strengths in the US. Enoxaparin Sodium Injection, USP is used for prophylaxis ...
 Pharmacy Choice1 week ago Eagle Pharmaceuticals : Teva and Eagle Pharmaceuticals Announce Teva's License to Commercialize Eagle's Bendamustine Rapid Infusion Product  4 Traders5 days ago

Impax Revenues Increased 30% to $131 Million in Fourth Quarter 2014

PR Newswire Association LLC HAYWARD, Calif., Feb. 24, 2015 /PRNewswire/ -- Impax Laboratories, Inc.(NASDAQ: IPXL) today reported total revenues increased 30.2% to $131.2 million for the fourth quarter ended December 31, 2014, compared to $100.7 ...
 Insurance News Net1 week ago
[x]  

Footprint steps into S.C. manufacturing scene

Staff Report colanews@scbiznews.com Published Feb. 19, 2015 Footprint LLC , a company specializing in manufacturing sustainable materials and packaging, has announced plans to invest $15.4 million in a new facility in Chester County. The ...
 Columbia Regional Business Report1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less